Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Peter Tang + 638 word(s) 638 2020-12-30 02:39:30

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Tang, P. JAK2 Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/5999 (accessed on 20 September 2026).
Tang P. JAK2 Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/5999. Accessed September 20, 2026.
Tang, Peter. "JAK2 Gene" Encyclopedia, https://encyclopedia.pub/entry/5999 (accessed September 20, 2026).
Tang, P. (2021, January 04). JAK2 Gene. In Encyclopedia. https://encyclopedia.pub/entry/5999
Tang, Peter. "JAK2 Gene." Encyclopedia. Web. 04 January, 2021.
JAK2 Gene
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/jak2

Janus kinase 2

genes

References

  1. Basquiera AL, Soria NW, Ryser R, Salguero M, Moiraghi B, Sackmann F, SturichAG, Borello A, Berretta A, Bonafé M, Barral JM, Palazzo ED, García JJ. Clinicalsignificance of V617F mutation of the JAK2 gene in patients with chronicmyeloproliferative disorders. Hematology. 2009 Dec;14(6):323-30. doi:10.1179/102453309X12473408860226. Citation on PubMed
  2. James C. The JAK2V617F mutation in polycythemia vera and othermyeloproliferative disorders: one mutation for three diseases? Hematology Am Soc Hematol Educ Program. 2008:69-75. doi: 10.1182/asheducation-2008.1.69. Review. Citation on PubMed
  3. Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M,Yallop D, Arya R, Pagliuca A, Gäken J, Wendon J, Heaton ND, Mufti GJ. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiarisyndrome. Gastroenterology. 2006 Jun;130(7):2031-8. Citation on PubMed
  4. Spivak JL. Narrative review: Thrombocytosis, polycythemia vera, and JAK2mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med. 2010 Mar 2;152(5):300-6. doi: 10.7326/0003-4819-152-5-201003020-00008. Review. Citation on PubMed
  5. Tefferi A. Novel mutations and their functional and clinical relevance inmyeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.Leukemia. 2010 Jun;24(6):1128-38. doi: 10.1038/leu.2010.69. Epub 2010 Apr 29.Review. Citation on PubMed or Free article on PubMed Central
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Peter Tang
View Times: 1.3K
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 04 Jan 2021
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback